Promoter hypomethylation up‐regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma
Open Access
- 30 May 2011
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 15 (6) , 1415-1428
Abstract
CD147 is a transmembrane glycoprotein overexpressed in human hepatocellular carcinoma (HCC) which could promote HCC progression and metastasis. Promoter methylation is one of the most important processes in gene regulation. In this study, we aim to investigate CD147 promoter methylation status and the correlation with clinicopathological features and prognosis in HCC. CD147 promoter methylation statuses and expression levels in normal and HCC cell lines and 54 paired HCC and adjacent non‐tumour (ANT) tissues were, respectively, examined by bisulphite genomic sequencing, methylation‐specific PCR, real‐time RT‐PCR, Western blot and immunohistochemistry. The correlations of promoter methylation statuses with CD147 expression level and the clinicopathological features were statistically analysed in HCC patients. Significantly higher expression of CD147 and significantly lower promoter methylation level were observed in HCC cell lines compared to normal cell lines and tissues control. In vivo and in vitro analysis indicated that demethylation with 5‐Aza‐2′‐deoxycytidine led to increased CD147 expression through enhancing Sp1 binding affinity, and methylation with methyltransferase reduced CD147 transcriptional activity through interfering Sp1 binding. CD147 promoter methylation level in HCC tissues (22.22%) was lower than that in ANT tissues (46.30%; P < 0.05). Within HCC tissues, a significant inverse correlation was observed between CD147 expression and methylation level (r=−0.615). Moreover, HCC patients with unmethylated CD147 promoter had a significantly higher recurrence rate (88.1%versus 58.3%; P < 0.05) and death rate (83.3%versus 50.0%; P < 0.05) than patients with methylated CD147 promoter. In conclusions, promoter hypomethylation up‐regulates CD147 expression primarily through increasing Sp1 binding and associates with poor prognosis in HCC patients.Keywords
This publication has 56 references indexed in Scilit:
- DNA demethylation-dependent enhancement of toll-like receptor-2 gene expression in cystic fibrosis epithelial cells involves SP1-activated transcriptionBMC Molecular Biology, 2008
- CpG methylation plays a vital role in determining tissue- and cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 bindingNucleic Acids Research, 2007
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- DNA methylation and gene silencing in cancerNature Clinical Practice Oncology, 2005
- Sp1‐dependent regulation of Myeloid Elf‐1 like factor in human epithelial cellsFEBS Letters, 2005
- The DNA methylation events in normal and cloned rabbit embryosFEBS Letters, 2004
- The history of cancer epigeneticsNature Reviews Cancer, 2004
- A decade?s studies on metastasis of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2003
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001